{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:15Z","timestamp":1793155815710,"version":"4.5.0"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.212570","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T14:55:26Z","timestamp":1555426526000},"page":"1-11","source":"Crossref","is-referenced-by-count":72,"title":["Brodalumab in psoriasis: evidence to date and clinical potential"],"prefix":"10.7573","volume":"8","author":[{"given":"Amy C","family":"Foulkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10047","published-online":{"date-parts":[[2019,4,17]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2019\/04\/dic.212570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T20:02:29Z","timestamp":1578686549000},"score":1,"resource":{"primary":{"URL":"https:\/\/drugsincontext.com\/brodalumab-in-psoriasis:-evidence-to-date-and-clinical-potential"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,17]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.212570","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,17]]}}}